Skip to main content
Clinical Trials/NCT02944344
NCT02944344
Completed
Not Applicable

Four Conversations Randomized Controlled Trial

Duke University1 site in 1 country357 target enrollmentDecember 15, 2016
ConditionsBreast Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Breast Cancer
Sponsor
Duke University
Enrollment
357
Locations
1
Primary Endpoint
Change in patient/caregiver decision making self-efficacy as measured by the Decision Self-efficacy Scale
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

The purpose of this study is to see whether patients with metastatic breast cancer, their caregivers, and their healthcare providers can improve in shared decision making (SDM) and preparedness around end of life (EOL) planning through participation in Reimagine's online Four Conversations™ program. The goal is to close clinical practice gaps and enhance the quality of care for patients with metastatic breast cancer through increased competence and performance of healthcare providers and healthcare systems.

Registry
clinicaltrials.gov
Start Date
December 15, 2016
End Date
October 21, 2018
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Diagnosed with metastatic breast cancer (MBC), caregiver to patient with MBC who is enrolled in this study, or MBC provider
  • Age ≥ 18 years
  • Internet access through a computer, laptop, tablet, or other mobile device
  • Able/willing to have an online interaction with a Reimagine Pillar Guide
  • Providing informed consent
  • Able to read/write English

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Change in patient/caregiver decision making self-efficacy as measured by the Decision Self-efficacy Scale

Time Frame: Baseline, Week 4 (waitlisted control only), Post-Intervention (Week 4 or 8)

The Decision Self-efficacy Scale is a reliable and validated instrument that measures self-confidence or belief in one's abilities in decision making, including shared decision making (SDM). Items are summed, divided by 11, and multiplied by 25. Scores range from 0 to 100 (very confident).

Change in patient self-conflict as measured by the Decisional Conflict Scale

Time Frame: Baseline, Week 4 (waitlisted control only), Post-Intervention (Week 4 or 8)

The Decisional Conflict scale is a reliable and validated measure of the state of uncertainty about a course of action. Items are summed, divided by 16, and multiplied by 25. Scores range from 0 to 100 (high decisional conflict).

Change in patient/caregiver and provider preparedness for decision making as measured by the Preparation for Decision Making Scale

Time Frame: Baseline, Week 4 (waitlisted control only), Post-Intervention (Week 4 or 8)

The Preparation for Decision Making Scale is a reliable and validated self-reported measure of the patient/caregiver or provider's perception of how useful a decision support intervention is in preparing the respondent to communicate with others making a health decision. Items are summed and scored, then divided by 10; scores can be converted to a 0-100 scale. Higher scores indicate higher perceived level of preparation for decision making.

Secondary Outcomes

  • Change in patient/caregiver and provider end of life (EOL) conversations as measured by EOL Conversations(Baseline, Week 4 (waitlisted control only), Post-Intervention (Week 4 or 8))
  • Change in provider end of life (EOL) care knowledge as measured by revised City of Hope EOL Knowledge Assessment(Baseline, Post-Intervention (Week 4))
  • Change in patient and caregiver quality of life (QOL) as measured by the PROMIS Global Scale(Baseline, Week 4 (waitlisted control only), Post-Intervention (Week 4 or 8))

Study Sites (1)

Loading locations...

Similar Trials